Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Family doctors say they can answer vaccine questions, after Trudeau recommends them

05/15/2021 | 04:03am EDT

Several family doctors and physician associations across Canada say they welcome questions from anyone concerned about second doses of Oxford-AstraZeneca or any other COVID-19 vaccine.

Dr. Eben Strydom, a generalist in Melfort, Sask., said he's happy to answer the call recommended by Prime Minister Justin Trudeau if it means giving his patients confidence in the vaccines.

"This is our ticket out of the pandemic so it is critically important," Strydom said. "If it means you're going to take it or not, you should speak to your doctor."

Trudeau said this week his own doctor recommended he get a second dose of AstraZeneca when it's his turn, adding that he knows scientists are also studying the effectiveness of mixing and matching vaccines.

Health Canada, the National Advisory Committee on Immunization and provincial health officials make recommendations about how and when Canadians can get vaccinated, Trudeau added.

"I certainly encourage all Canadians to talk to their doctors."

More than two million Canadians got AstraZeneca for their first jab.

Since then, Alberta, British Columbia and Saskatchewan said they would reserve remaining doses for second shots due to limited supply. Ontario paused its use over concerns about rare blood clots.

Keir Johnson, a spokesperson for Manitoba Doctors, said physicians are keeping up with the new evidence and shifting recommendations but it's understandable why the pauses and shifting eligibility could create concern for the public.

The association has a campaign encouraging anyone with concerns to speak with a doctor and in most cases members report that patients feel more confident after that conversation, Johnson said.

"Because physicians are a trusted voice, they're often able to reassure people to help them understand the current benefits and risks," he said.

That said, there has not been any deluge of new questions since Trudeau's recommendation, he added.

Dr. Noah Ivers, a family doctor at Women's College Hospital in Toronto, said the pandemic has prompted some doctors to engage with their patients in new ways.

He and some colleagues have started holding virtual town halls to address common questions. A town hall on COVID-19 vaccines attracted about 1,000 participants who could type in questions and upvote the most popular ones.

"It's gone so well, I started to wonder why we didn't do it before," he said.

On an individual basis, family doctors also have the benefit of knowing a patient's health history. If an individual has had a recent kidney transplant, for example, a physician may recommend a shorter gap between doses than for a totally healthy individual, he said.

Generally speaking, he said he tells his patients the same thing he tells his parents, whose first jab was AstraZeneca.

"We are in no rush to figure this out and we're waiting for information," Ivers said, adding the recommended gap between doses means there's plenty of time for more research on mixing of manufacturers and blood clot risks.

Of course, not everyone has access to a family doctor. The Liberals' own 2019 platform promised to make sure every Canadian has access to a family doctor or primary health-care team, noting nearly five million Canadians don't have access.

Ivers said vaccine hesitancy is another reason why governments should be making access to a family doctor a priority.

"I think this is one in a million reasons why you really need to get connected to a primary care professional," he said.

"It's time to write a letter to your MP and MPP about how important primary care is," he said.

Dr. Matthew Chow, president of Doctors of BC, said like Ivers, other doctors are finding new ways to interact and share information widely with their patients.

The South Asian COVID Task Force — a volunteer organization made up of physicians, researchers and others — has chapters across the country. They are sharing culturally appropriate communications about COVID-19 in multiple South Asian languages, he said.

Doctors understand the pandemic has been tough on the public in many ways and keeping track of shifting evidence is one of them, he said.

However, family doctors are evidence-based practitioners who take their information and best guidance from federal authorities such as Health Canada and the National Advisory Committee on Immunization, who in turn are monitoring international evidence, he said.

"We can be confident those recommendations will be safe," he said.

This report by The Canadian Press was first published May 15, 2021.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about ASTRAZENECA PLC
06/11ASTRAZENECA  : COVID-19 hot spot mayors want shorter dose interval for AstraZene..
AQ
06/11FDA Approves Export of Covid-19 Vaccine Doses From Troubled Baltimore Plan --..
DJ
06/11ASTRAZENECA  : U.S. FDA asks J&J to discard millions of COVID-19 vaccine doses
RE
06/11FDA Approves Export of Covid-19 Vaccine Doses from Troubled Baltimore Plant
DJ
06/11Drug Experts Explore Mixing COVID-19 Jabs Despite Side Effect Risks
MT
06/11"WE NEED MORE" : UN joins criticism of G7 vaccine pledge
RE
06/10U.S. Covid-19 Vaccine Donation to Boost Developing World's Pandemic Fight -- ..
DJ
06/10MARKET CHATTER : Malaysia Expecting Delay in AstraZeneca Vaccines Delivery
MT
06/10CHALMERS UNIVERSITY OF TECHNOLOGY : Researchers monitor mRNA to help time its gr..
AQ
06/10ASTRAZENECA  : Expects Prompt Delivery Of COVID-19 Vaccine Doses To Southeast As..
MT
More news
Financials (USD)
Sales 2021 31 008 M - -
Net income 2021 4 562 M - -
Net Debt 2021 10 731 M - -
P/E ratio 2021 33,9x
Yield 2021 2,42%
Capitalization 154 B 154 B -
EV / Sales 2021 5,33x
EV / Sales 2022 4,67x
Nbr of Employees 76 100
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 132,38 $
Last Close Price 117,64 $
Spread / Highest target 45,3%
Spread / Average Target 12,5%
Spread / Lowest Target -18,2%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC13.87%154 435
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857